Federal grants to Thetis Pharmaceuticals LLC
Thetis Pharmaceuticals LLC in Deep River, Connecticut received $5.4 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $3.0 million. In fiscal 2025 it was awarded $2.7 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$5.4 million
- Awards3
- Awarded in FY 2025$2.7 million
- Largest award$3.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $299,561 |
| FY 2022 | 0 | $0 |
| FY 2023 | 2 | $1.4 million |
| FY 2024 | 1 | $999,624 |
| FY 2025 | 2 | $2.7 million |
Programs that fund Thetis Pharmaceuticals LLC
| Program | Awards | Amount |
|---|---|---|
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $3.0 million |
| Cancer Treatment Research | 1 | $2.1 million |
| Allergy and Infectious Diseases Research | 1 | $299,561 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $5.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of TP-317 for the induction and maintenance of remission in ulcerative colitis patients | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 13, 2021 | $3.0 million |
| Development of a novel resolvin-based therapy for treatment of pancreatic cancer - abstract pancreatic cancer (PC) is a highly lethal disease with a 5-YEAR survival rate between 5% and 10%. Pc incidence and mortality are projected to more than double over the next ten years. However, existing system | Cancer Treatment Research | June 2, 2023 | $2.1 million |
| Development of a novel resolvin-based therapy for the prevention and treatment of acute respiratory distress syndrome (ARDS) - abstract acute respiratory distress syndrome (ARDS) is a life-threatening lung injury characterized by an acute inflammatory response leading to lung and organ failure. It i | Allergy and Infectious Diseases Research | August 6, 2021 | $299,561 |
Questions people ask
How much federal grant money does Thetis Pharmaceuticals LLC get?
$5.4 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Thetis Pharmaceuticals LLC the most?
The Department of Health and Human Services, with $5.4 million in 3 awards.
What is Thetis Pharmaceuticals LLC's largest federal grant?
$3.0 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on August 13, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Thetis Pharmaceuticals LLC?
Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research, Cancer Treatment Research and Allergy and Infectious Diseases Research.
Largest federal grant recipients in Connecticut · Federal grants in Connecticut